Walgreens Boots Alliance Earnings Preview

Walgreens Boots Alliance WBA is gearing up to announce its quarterly earnings on Tuesday, 2025-04-08. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Walgreens Boots Alliance will report an earnings per share (EPS) of $0.54.

The announcement from Walgreens Boots Alliance is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Earnings Track Record

The company's EPS beat by $0.14 in the last quarter, leading to a 0.0% drop in the share price on the following day.

Here's a look at Walgreens Boots Alliance's past performance and the resulting price change:

Stock Performance

Shares of Walgreens Boots Alliance were trading at $10.68 as of April 04. Over the last 52-week period, shares are down 47.18%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

Analyst Insights on Walgreens Boots Alliance

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Walgreens Boots Alliance.

With 6 analyst ratings, Walgreens Boots Alliance has a consensus rating of Neutral. The average one-year price target is $11.08, indicating a potential 3.75% upside.

Comparing Ratings Among Industry Peers

In this analysis, we delve into the analyst ratings and average 1-year price targets of and Walgreens Boots Alliance, three key industry players, offering insights into their relative performance expectations and market positioning.

Peer Metrics Summary

The peer analysis summary provides a snapshot of key metrics for and Walgreens Boots Alliance, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

Key Takeaway:

Walgreens Boots Alliance ranks in the middle among peers for consensus rating. It is at the bottom for revenue growth. It is at the top for gross profit. It is at the bottom for return on equity.

Get to Know Walgreens Boots Alliance Better

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Walgreens Boots Alliance's Economic Impact: An Analysis

Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.

Revenue Growth: Over the 3 months period, Walgreens Boots Alliance showcased positive performance, achieving a revenue growth rate of 7.5% as of 30 November, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.

Net Margin: Walgreens Boots Alliance's net margin is impressive, surpassing industry averages. With a net margin of -0.67%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Walgreens Boots Alliance's ROE stands out, surpassing industry averages. With an impressive ROE of -2.6%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.33%, the company showcases effective utilization of assets.

Debt Management: With a high debt-to-equity ratio of 3.09, Walgreens Boots Alliance faces challenges in effectively managing its debt levels, indicating potential financial strain.

To track all earnings releases for Walgreens Boots Alliance visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.